Page 25 - Pharma Industry

Amazon may invest $100 million in India's Apollo Pharmacy: Report

Amazon is considering a nearly $100 million investment in India's Apollo Pharmacy, facing up to Reliance Industries and Tata Group in the country's fast-growing drug market, a report said

November domestic pharma sales grow just 1% after strong show last month

Oct growth rate was 9.6%; Most big corporates saw volumes drop in November

Moderna to supply up to 125 mn Covid vaccine doses globally in 1st quarter

Moderna said it expects to have between 100 million and 125 million doses of its experimental Covid-19 vaccine available globally in the first quarter of 2021

Alembic Pharma gets USFDA nod for pills to treat salt, water retention

Alembic Pharmaceuticals said it received approval from the US health regulator for Metolazone tablets, indicated for the treatment of salt and water retention caused by heart failure or kidney disease

Strides Pharma Science gets USFDA nod for generic Prednisone tablets

Strides Pharma Science Ltd on Monday said it has received approval from the US health regulator for its generic version of Prednisone tablets, prescribed for a variety of conditions, including allergies, respiratory illness and arthritis. The approval for Prednisone tablets by the US Food & Drug Administration (USFDA) granted to the company's step-down wholly owned subsidiary, Strides Pharma Global Pte Limited, Singapore, is for multiple strengths of 2.5 mg and 5 mg, Strides Pharma Science said in a regulatory filing. The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Deltasone tablets, 2.5 mg and 5 mg, of Pharmacia and Upjohn Co, it added. Citing IQVIA MAT September 2020 data, the company said the US market for Prednisone Tablets USP, 2.5 mg and 5 mg is approximately USD 30 million. "The product will be manufactured at the company's flagship facility at Bengaluru and will be marketed by Strides Pharma Inc in the US market," it ...

We can stop Covid-19: Moderna vaccine success gives world more hope

Moderna's experimental vaccine is 94.5% effective in preventing Covid-19 based on data from a late-stage trial, it said, becoming the second US drugmaker to report results that far exceed expectations

Govt to launch PLI schemes for 10 sectors in 45 days. Is it overambitious?

By setting a deadline of 45 days for extending the scheme to 10 industries, the government may be ignoring the critical demands of the targeted industries

World Health Organization to set up traditional medicine centre in India

World Health Organisation said it will set up a Global Centre for Traditional Medicine in India, with PM Mod expressing confidence that just like the country has emerged as the 'pharmacy of the world'

Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug

Natco Pharma said its marketing partner Breckenridge Pharmaceutical received final approval from the USFDA for Pomalidomide Capsules, treatment of patients suffering from multiple myeloma cancer

Have enough data for first interim analysis of Covid-19 vaccine: Moderna

Moderna said it has enough data for a first interim analysis of the late-stage trial of its experimental Covid-19 vaccine, which should help determine the vaccine's efficacy

Govt expands Rs 1.45 trn PLI scheme to 10 key sectors, industry hails move

The scheme is in addition to the already announced Rs 51,311 crore PLI for three sectors which takes the total around Rs 2 trn

Five questions you should be asking about Pfizer's coronavirus vaccine

Important scientific announcements are usually made through peer-reviewed medical research papers, not company press releases

Eli Lilly's Covid-19 antibody drug treatment gets emergency USFDA clearance

The FDA authorised the experimental treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adults, including those who are 65 and older, and pediatric patients

Intas launches immuno-booster add-on drug to standard Covid-19 treatment

The formulation is the active biological component of black cumin; it fortifies the immunity and ensures higher success in fighting infection, the company says

USFDA issues 13 observations after inspection of Lupin arm's facility in US

Drug firm Lupin said the US health regulator has issued 13 observations after inspection of its subsidiary's Somerset facility in New Jersey

Alembic Pharma gets tentative USFDA nod for breast cancer treatment drug

Drug firm Alembic Pharmaceuticals said it has received tentative approval from the US health regulator for Palbociclib capsules, used to treat a certain type of breast cancer

US presidential election results may not impact Indian pharma industry

Europe, not India, will be the 1st target if US reduces import dependence: Experts

Cipla posts net profit of Rs 665 cr in Q2, income from ops grows 15%

The company's prescription biz grew 14% YoY supported by continued traction in the Covid portfolio

India's largest pharma IPO worth Rs 6,500 cr set to hit market next week

Fosun-owned Gland Pharma sets price band for its IPO at Rs 1,490-1,500 per share

Smaller pharma firms post faster domestic sales growth in September

Barring Cipla and Glenmark, whose sales have grown in double digits due to demand for their Covid-19 drugs like favipiravir, tocilizumab, most big players have posted tepid growth